M&A Deal Summary

IMCD Acquires Cobapharma

On April 24, 2024, IMCD acquired life science company Cobapharma

Acquisition Highlights
  • This is IMCD’s 1st transaction in the Life Science sector.
  • This is IMCD’s 1st transaction in Spain.

M&A Deal Summary

Date 2024-04-24
Target Cobapharma
Sector Life Science
Buyer(s) IMCD
Deal Type Add-on Acquisition

Target

Cobapharma

Barcelona, Spain
website
Cobapharma is a European distributor in the pharmaceutical and nutraceutical industry. The company provides an extensive portfolio of Active Pharmaceutical Ingredients (APIs) as well as nutraceutical ingredients. Cobapharma was formed in 2011 and is based in Barcelona, Spain.

Search 193,092 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

IMCD

Rotterdam, Netherlands

website


Category Company
Founded 1995
Sector Chemicals
Employees4,013
Revenue 3.4B EUR (2021)
DESCRIPTION

IMCD is a marketing, sales and distribution of specialty chemicals and food- and pharma ingredients, with offices and warehouses in 31 countries in Europe, Africa and Australia/Asia. IMCD was founded in 1995 and is based in Rotterdam, the Netherlands.


DEAL STATS #
Overall 56 of 56
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 50 of 50
Country (Spain) 1 of 1
Year (2024) 4 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-03-20 Bretano

Santo Domingo, Costa Rica

Bretano is a specialty ingredients distributor in Latin America for the food industry and supplies chemicals to construction and other industrial markets. Established in 1961, Bretano is headquartered in Costa Rica, with commercial and logistics operations in Mexico, Guatemala and El Salvador

Buy -